BEUDAMED
    FDA Adverse Event Injury Summary report: N

    QUANTIFERON®-TB GOLD PLUS

    MDR report key: 18817510 · Received February 29, 2024

    Report

    Report Number
    MW5152238
    Event Type
    Injury
    Date Received
    February 29, 2024
    Date of Event
    September 20, 2020
    Report Date
    February 13, 2024
    Manufacturer
    QIAGEN
    Product Code
    NCD
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Voluntary report
    Reporter Location
    MA, US
    Reporter Occupation
    PATIENT
    Health Professional
    *

    Narratives

    Description of Event or Problem · 0

    (B)(6) MISDIAGNOSED ME. THE CLINIC EVENTUALLY MADE ME GO UNDER TREATMENT OF ANTIBIOTICS MY BODY DIDN'T NEED. NOW, MY BODY IS ANTIBIOTIC RESISTANT AND I'M SUFFERING FROM MULTIPLE STOMACH INFECTIONS. TUBERCULOSIS SCREEN, POSITIVE PPD/ IGRA. MY CURRENT MEDICAL PROVIDER AT THE (B)(6) UPDATED MY FILE TO REFLECT I'M NEGATIVE TESTER BUT CAN'T UNDO THE FACT THAT I WAS TREATED WITH ANTIBIOTICS MY BODY DIDN'T NEED. MAKING IT AN OVERUSE OF ANTIBIOTICS. MY BODY HAS BECOME ANTIBIOTIC RESISTANT AND I UNABLE TO FIGHT OFF STOMACH INFECTIONS. I HAD A BABY (B)(6) 2019 AND MY BABY HAS MULTIPLE DISABILITIES. LTBI (LATENT TUBERCULOSIS INFECTION) TESTED: (B)(6) 2018, 12 DOSES OF LTBI 3HP MY BODY CLEARLY DIDN'T NEED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    696349 QUANTIFERON®-TB GOLD PLUS TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS NCD QIAGEN

    Patients

    Seq Age Sex Outcome Treatment
    1 32 YR Female Congenital Anomaly| O| S